Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Quantitative evaluation of range and metabolic activity of hepatic alveolar echinococcosis lesion microenvironment using PET/CT and multi-site sampling method

Fig. 2

CT and PET/CT features plus gross specimens of patients in each groups. Group A: 0% periphery calcified (−/non-calcified), 0% central liquefied (−); Group B: ≥50% periphery calcified (++/macro-calcified), 0% central liquefied (−); Group C: < 50% periphery calcified (+/micro-calcified), < 50% central liquefied (+); Group D: ≥50% periphery calcified (++/macro-calcified), < 50% central liquefied (+); Group E: < 50% periphery calcified (+/micro-calcified), 50 ~ 75% central liquefied (++); Group F: ≥50% periphery calcified (++/macro-calcified), ≥75% central liquefied (++)

Back to article page